Cachexia, Fatigue, Pulmonary Complications, Radiation Toxicity, Recurrent Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
Conditions
Keywords
Pulmonary Rehabilitation, Non-Small Cell Lung Cancer, NSCLC
Brief summary
This randomized clinical trial studies pulmonary rehabilitation in improving lung function in patients with locally advanced non-small cell lung cancer undergoing chemoradiation. Individualized exercise rehabilitation programs may reduce breathing problems and improve quality of life in patients with non-small cell lung cancer. It is not yet known whether pulmonary rehabilitation is more effective when started during or after cancer treatment.
Detailed description
PRIMARY OBJECTIVES: I. To determine feasibility of pulmonary rehabilitation (PR) in patients with locally advanced unresectable non-small cell lung cancer (NSCLC) undergoing definite chemotherapy and radiation therapy. II. To measure exercise capacity and respiratory symptoms in lung cancer patients receiving chemotherapy and radiation before and after pulmonary rehabilitation. III. To compare if there are any differences in symptom relief, exercise capacity, and cancer treatment tolerability between performing pulmonary rehabilitation during chemo-radiation versus after completion of lung cancer treatment. OUTLINE: Patients are randomized to 1 of 2 arms. ARM I: Beginning within 2 weeks of starting chemoradiation, patients undergo an individualized rehabilitation program comprising aerobic exercise and strength training, including treadmill walking, stationary bicycle, NU-Step, upper body resistance training and breathing retraining, 3 times per week for 8 weeks (36 sessions). ARM II: Beginning 1 month after completion of chemoradiation, patients undergo an individualized exercise rehabilitation program as in Arm I.
Interventions
BEHAVIORALexercise intervention
Undergo pulmonary rehabilitation
Undergo pulmonary rehabilitation
PROCEDUREquality-of-life assessment
Ancillary studies
OTHERquestionnaire administration
Ancillary studies
Sponsors
Ohio State University Comprehensive Cancer Center
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patients who have been diagnosed with locally advanced unresectable NSCLC undergoing definite chemo-radiation with curative intent * Patients must be able to sign informed consent * Patients who qualify for pulmonary rehabilitation as part of the standard of care and are covered by medical insurance * Patients must be able to ambulate a minimum of 100 feet prior to enrollment in pulmonary rehab * Patients must be willing and able to travel to the pulmonary rehabilitation site at the Morehouse Medical Plaza
Exclusion criteria
* Tumor resection candidates * If survival is deemed less than 6 months for any medical condition * If they have angina or unstable coronary disease * Congestive heart failure refractory to medical management * Malignancy with bone instability * Inmates
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Percent improvement in the 6 minute walk from prior to post PR | Baseline to up to 8 weeks | Either a two-sided t-test or a Wilcoxon-rank sum test will be used to test the difference in the improvement of the 6 minute walk depending on the distribution. This test will be used to compare the difference in improvement between PR during chemo-radiation of NSCLC patients and PR 8 weeks post chemo-radiation. Linear regression will be used to estimate which clinical characteristics and patient demographics are associated with improvement in 6 minute walk. The study population will be described using means and standard deviations or medians and the interquartile range. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Percent improvement in the St. George Respiratory Questionnaire (SGRQ) score | Baseline to up to 8 weeks | — |
| Feasibility of the program, based on number of patients attending the sessions throughout the 8 weeks | Up to 8 weeks | Either Pearson's chi-square of Fisher's exact methods will be used to test if the feasibility differs across groups. Logistic regression will be used to estimate which clinical characteristics and patient demographics are associated with feasibility. |
Outcome results
None listed